Knowledge Distillery

Filter the news according their assigned tags.
| Randomised double-blinded placebo-controlled trial  

Tocilizumab in hospitalized patients with severe COVID-19 pneumonia

 

more...
| Randomised double-blinded placebo-controlled trial  

Efficacy of the ChAdOx1 nCoV-19 COVID-19 vaccine against the B.1.351 variant

 

more...
| Randomised double-blinded placebo-controlled trial  

Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized…

more...
| Randomised double-blinded placebo-controlled trial  

Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: a randomized clinical trial

 

more...
| Randomised double-blinded placebo-controlled trial  

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase…

more...
| Randomised double-blinded placebo-controlled trial  

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised,…

more...
| Randomised double-blinded placebo-controlled trial  

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial

 

more...
| Randomised double-blinded placebo-controlled trial  

The emergence of SARS-CoV-2 variants threatens progress toward control of the Covid-19 pandemic. In a phase 1–2 trial involving healthy adults, the…

more...
| Randomised double-blinded placebo-controlled trial  

The objective of this multicenter randomized clinical trial was to assess whether helmet noninvasive ventilation can increase the days free of…

more...
| Randomised double-blinded placebo-controlled trial  

The objective of this randomized clinical trial was to determine whether hydroxychloroquine or lopinavir-ritonavir reduces hospitalization among…

more...
| Randomised double-blinded placebo-controlled trial  

A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. In this article the authors…

more...
| Randomised double-blinded placebo-controlled trial  

In this phase 1, double-blind, placebo-controlled, block-randomised trial the authors aimed to assess the safety and immunogenicity of an…

more...